Zoll Medical Corporation (ZOLL) - NASDAQ
ZOLL is defunct since April 30, 2012. acquired by a private company
  • Jan. 20, 2012, 9:58 AM

    Zoll Medical (ZOLL +5.8%) surges at the open following strong FQ1 results which showed revenue from its LifeVest wearable defibrillator worn by patients at risk for sudden cardiac arrest, jumped 45% to $32.3M and now accounts for 20% of revenue. Zoll seems back on track after the strong quarter and Medicare's recent reversal of a decision to change its coverage policy.

    | Jan. 20, 2012, 9:58 AM
  • Jan. 19, 2012, 4:52 PM
    Zoll Medical (ZOLL): FQ1 EPS of $0.18 misses by $0.09. Revenue of $133.8M (+18% Y/Y) in-line. (PR)
    | Jan. 19, 2012, 4:52 PM
  • Nov. 17, 2011, 9:42 AM

    Zoll Medical (ZOLL) +18.8% at the open, after reporting FQ4 EPS of $0.52, vs. $0.33 in the year-ago period and better than analyst estimates of $0.49, and a 65% rise in profit on strong sales of its LifeVest device. The maker of defibrillators forecasts 2012 revenue will rise as much as 19% vs. analyst consensus of ~16%, and reports a $50M share buyback program.

    | Nov. 17, 2011, 9:42 AM
  • Jul. 29, 2011, 11:46 AM

    Zoll Medical (ZOLL +25%) soars after FQ3 earnings easily blows out estimates. Revenues jumped 22% Y/Y, driven by higher defibrillator sales after larger hospitals - who have been sitting on the sidelines for the past couple of years - are stepping up purchases.

    | Jul. 29, 2011, 11:46 AM
Company Description
Currently, there's no company description for ZOLL.
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States